Therapeutic applications of hypothermia in cerebral ischaemia.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 3002547)

Published in Ther Adv Neurol Disord on September 01, 2008

Authors

Bruno P Meloni1, Frank L Mastaglia, Neville W Knuckey

Author Affiliations

1: Australian Neuromuscular Research Institute A Block, 1st Floor QEII Medical Centre Nedlands, Western Australia, Australia 6009. meloni@cyllene.uwa.edu.au

Articles citing this

Neuroprotective mechanisms of hypothermia in brain ischaemia. Nat Rev Neurosci (2012) 2.02

Articles cited by this

(truncated to the top 100)

Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med (2002) 22.37

Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med (2002) 21.40

Delay in cooling negates the beneficial effect of mild resuscitative cerebral hypothermia after cardiac arrest in dogs: a prospective, randomized study. Crit Care Med (1993) 3.46

Mild therapeutic hypothermia in patients after out-of-hospital cardiac arrest due to acute ST-segment elevation myocardial infarction undergoing immediate percutaneous coronary intervention. Crit Care Med (2008) 3.10

Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J Cereb Blood Flow Metab (1987) 3.04

Mild hypothermic cardiopulmonary resuscitation improves outcome after prolonged cardiac arrest in dogs. Crit Care Med (1991) 2.96

Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis. Brain (2007) 2.94

From evidence to clinical practice: effective implementation of therapeutic hypothermia to improve patient outcome after cardiac arrest. Crit Care Med (2006) 2.48

Intra-arrest cooling improves outcomes in a murine cardiac arrest model. Circulation (2004) 2.42

Feasibility and safety of moderate hypothermia after massive hemispheric infarction. Stroke (2001) 2.26

Induced hypothermia in critical care medicine: a review. Crit Care Med (2003) 2.26

Pilot randomized clinical trial of prehospital induction of mild hypothermia in out-of-hospital cardiac arrest patients with a rapid infusion of 4 degrees C normal saline. Circulation (2007) 2.18

Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke (1998) 1.95

Efficacy and safety of endovascular cooling after cardiac arrest: cohort study and Bayesian approach. Stroke (2006) 1.84

Critical time window for intra-arrest cooling with cold saline flush in a dog model of cardiopulmonary resuscitation. Circulation (2006) 1.84

Hypothermia but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia. J Neurosci (1990) 1.84

Delayed postischemic hypothermia: a six month survival study using behavioral and histological assessments of neuroprotection. J Neurosci (1995) 1.82

Induced hypothermia for acute stroke. Stroke (2007) 1.82

Neurological impairment in rats after transient middle cerebral artery occlusion: a comparative study under various treatment paradigms. Brain Res (2000) 1.65

Cooling for Acute Ischemic Brain Damage (COOL AID): a feasibility trial of endovascular cooling. Neurology (2004) 1.65

Mild hypothermia during prolonged cardiopulmonary cerebral resuscitation increases conscious survival in dogs. Crit Care Med (2004) 1.62

Cooling for acute ischemic brain damage (cool aid): an open pilot study of induced hypothermia in acute ischemic stroke. Stroke (2001) 1.62

Intraischemic but not postischemic brain hypothermia protects chronically following global forebrain ischemia in rats. J Cereb Blood Flow Metab (1993) 1.59

Optimal depth and duration of mild hypothermia in a focal model of transient cerebral ischemia: effects on neurologic outcome, infarct size, apoptosis, and inflammation. Stroke (1998) 1.57

Postischemic (1 hour) hypothermia significantly reduces ischemic cell damage in rats subjected to 2 hours of middle cerebral artery occlusion. Stroke (1993) 1.55

Mild hypothermia induced by a helmet device: a clinical feasibility study. Resuscitation (2001) 1.51

A prospective, multicenter pilot study to evaluate the feasibility and safety of using the CoolGard System and Icy catheter following cardiac arrest. Resuscitation (2004) 1.46

Electron microscopic evidence against apoptosis as the mechanism of neuronal death in global ischemia. J Neurosci (1999) 1.45

Therapeutic hypothermia with a novel surface cooling device improves neurologic outcome after prolonged cardiac arrest in swine. Crit Care Med (2008) 1.41

Prolonged but delayed postischemic hypothermia: a long-term outcome study in the rat middle cerebral artery occlusion model. J Cereb Blood Flow Metab (2000) 1.34

The effect of mild hyperthermia and hypothermia on brain damage following 5, 10, and 15 minutes of forebrain ischemia. Ann Neurol (1990) 1.34

Postischemic moderate hypothermia inhibits CA1 hippocampal ischemic neuronal injury. Neurosci Lett (1989) 1.33

Effects of hypothermia for a short period on histologic outcome and extracellular glutamate concentration during and after cardiac arrest in rats. Crit Care Med (2005) 1.32

Delayed induction and long-term effects of mild hypothermia in a focal model of transient cerebral ischemia: neurological outcome and infarct size. J Neurosurg (2001) 1.30

Delayed and prolonged post-ischemic hypothermia is neuroprotective in the gerbil. Brain Res (1994) 1.26

Novel thyroxine derivatives, thyronamine and 3-iodothyronamine, induce transient hypothermia and marked neuroprotection against stroke injury. Stroke (2007) 1.23

Hypothermia to treat neonatal hypoxic ischemic encephalopathy: systematic review. Arch Pediatr Adolesc Med (2007) 1.22

Postischemic hypothermia and IL-10 treatment provide long-lasting neuroprotection of CA1 hippocampus following transient global ischemia in rats. Exp Neurol (1999) 1.21

A trial of therapeutic hypothermia via endovascular approach in awake patients with acute ischemic stroke: methodology. Acad Emerg Med (2006) 1.20

Postischemic hypothermia. A critical appraisal with implications for clinical treatment. Mol Neurobiol (1997) 1.19

Buspirone and meperidine synergistically reduce the shivering threshold. Anesth Analg (2001) 1.17

Hypothermia during reperfusion after asphyxial cardiac arrest improves functional recovery and selectively alters stress-induced protein expression. J Cereb Blood Flow Metab (2000) 1.17

Cognitive and neurophysiological outcome of cardiac arrest survivors treated with therapeutic hypothermia. Stroke (2007) 1.16

Feasibility and safety of inducing modest hypothermia in awake patients with acute stroke through surface cooling: A case-control study: the Copenhagen Stroke Study. Stroke (2000) 1.15

The effect of hypothermia on transient middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab (1992) 1.14

Intravascular Cooling in the Treatment of Stroke (ICTuS): early clinical experience. J Stroke Cerebrovasc Dis (2007) 1.14

Mild cerebral hypothermia during and after cardiac arrest improves neurologic outcome in dogs. J Cereb Blood Flow Metab (1990) 1.12

Mild hypothermia prevents ischemic injury in gerbil hippocampus. J Cereb Blood Flow Metab (1990) 1.11

Improved cerebral resuscitation from cardiac arrest in dogs with mild hypothermia plus blood flow promotion. Stroke (1996) 1.11

Time is brain--acute stroke management. Aust Fam Physician (2007) 1.10

Therapeutic time window of post-ischemic mild hypothermia and the gene expression associated with the neuroprotection in rat focal cerebral ischemia. Neurosci Res (2007) 1.10

Rapid and selective cerebral hypothermia achieved using a cooling helmet. J Neurosurg (2004) 1.08

Protection against hippocampal CA1 cell loss by post-ischemic hypothermia is dependent on delay of initiation and duration. Metab Brain Dis (1992) 1.08

Beneficial effect of mild hypothermia and detrimental effect of deep hypothermia after cardiac arrest in dogs. Stroke (1992) 1.07

Endovascular cooling for moderate hypothermia in patients with acute stroke: first results of a novel approach. Stroke (2001) 1.06

Comparative neuroprotective efficacy of prolonged moderate intraischemic and postischemic hypothermia in focal cerebral ischemia. J Neurosurg (2000) 1.05

Comparison of 12, 24 and 48 h of systemic hypothermia on outcome after permanent focal ischemia in rat. Exp Neurol (2008) 1.05

Rapid implementation of therapeutic hypothermia in comatose out-of-hospital cardiac arrest survivors. Acta Anaesthesiol Scand (2006) 1.04

The significance of brain temperature in focal cerebral ischemia: histopathological consequences of middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab (1992) 1.03

Conditions of protection by hypothermia and effects on apoptotic pathways in a rat model of permanent middle cerebral artery occlusion. J Neurosurg (2007) 1.03

Hypothermia rescues hippocampal CA1 neurons and attenuates down-regulation of the AMPA receptor GluR2 subunit after forebrain ischemia. Proc Natl Acad Sci U S A (2003) 1.03

Combination of intraischemic and postischemic hypothermia provides potent and persistent neuroprotection against temporary focal ischemia in rats. Stroke (1999) 1.02

Antiedema therapy in ischemic stroke. Stroke (2007) 1.02

Mild hypothermic intervention after graded ischemic stress in rats. Stroke (1991) 1.02

Hypothermic protection in rat focal ischemia models: strain differences and relevance to "reperfusion injury". J Cereb Blood Flow Metab (2004) 1.02

Mild hypothermia: therapeutic window after experimental cerebral ischemia. Neurosurgery (1996) 1.00

Indefatigable CA1 sector neuroprotection with mild hypothermia induced 6 hours after severe forebrain ischemia in rats. J Cereb Blood Flow Metab (1999) 0.99

Mild hypothermia enhances the neuroprotective effects of FK506 and expands its therapeutic window following transient focal ischemia in rats. Brain Res (2004) 0.99

Ethanol plus caffeine (caffeinol) for treatment of ischemic stroke: preclinical experience. Stroke (2003) 0.99

Long-lasting neuroprotective effect of postischemic hypothermia and treatment with an anti-inflammatory/antipyretic drug. Evidence for chronic encephalopathic processes following ischemia. Stroke (1996) 0.99

Moderate hypothermia after cardiac arrest of 17 minutes in dogs. Effect on cerebral and cardiac outcome. Stroke (1990) 0.98

Different degrees of hypothermia after experimental stroke: short- and long-term outcome. Stroke (2007) 0.98

Persistent neuroprotection with prolonged postischemic hypothermia in adult rats subjected to transient middle cerebral artery occlusion. Exp Neurol (2000) 0.97

Hypothermia and brain-derived neurotrophic factor reduce glutamate synergistically in acute stroke. Exp Neurol (2004) 0.97

Moderate hypothermia mitigates neuronal damage in the rat brain when initiated several hours following transient cerebral ischemia. Acta Neuropathol (1994) 0.96

The ischemic penumbra: a new opportunity for neuroprotection. Cerebrovasc Dis (2006) 0.96

Mild hypothermia reduces infarct size resulting from temporary but not permanent focal ischemia in rats. Stroke (1992) 0.94

Combination of decompressive craniectomy and mild hypothermia ameliorates infarction volume after permanent focal ischemia in rats. Stroke (2001) 0.94

Therapeutic hypothermia after cardiac arrest: performance characteristics and safety of surface cooling with or without endovascular cooling. Neurocrit Care (2007) 0.94

Induction and maintenance of mild hypothermia by surface cooling in non-intubated subjects. J Stroke Cerebrovasc Dis (2007) 0.93

Prolonged mild hypothermia therapy protects the brain against permanent focal ischemia. Stroke (2001) 0.93

Hypothermic neuroprotection. A global ischemia study using 18- to 20-month-old gerbils. Stroke (1997) 0.92

Postischemic hypothermia fails to reduce ischemic injury in gerbil hippocampus. J Cereb Blood Flow Metab (1991) 0.92

Reduction by delayed hypothermia of cerebral infarction following middle cerebral artery occlusion in the rat: a time-course study. J Neurosurg (1992) 0.91

Hemicraniectomy and moderate hypothermia in patients with severe ischemic stroke. Stroke (2002) 0.90

Postischemic mild hypothermia reduces neurotransmitter release and astroglial cell proliferation during reperfusion after asphyxial cardiac arrest in rats. Brain Res (2004) 0.90

Post-ischemic modest hypothermia (35 degrees C) combined with intravenous magnesium is more effective at reducing CA1 neuronal death than either treatment used alone following global cerebral ischemia in rats. Exp Neurol (2005) 0.89

Effect of resuscitative mild hypothermia on glutamate and dopamine release, apoptosis and ischaemic brain damage in the endothelin-1 rat model for focal cerebral ischaemia. J Neurochem (2003) 0.89

Immediate or delayed mild hypothermia prevents focal cerebral infarction. Brain Res (1992) 0.88

Coenzyme Q10 combined with mild hypothermia after cardiac arrest: a preliminary study. Circulation (2004) 0.88

Delayed induction of mild hypothermia to reduce infarct volume after temporary middle cerebral artery occlusion in rats. J Neurosurg (1994) 0.88

Combined magnesium and mild hypothermia (35 degrees C) treatment reduces infarct volumes after permanent middle cerebral artery occlusion in the rat at 2 and 4, but not 6 h. Brain Res (2008) 0.87

Neuroprotection after several days of mild, drug-induced hypothermia. J Cereb Blood Flow Metab (1996) 0.87

Combined postischemic hypothermia and delayed MK-801 treatment attenuates neurobehavioral deficits associated with transient global ischemia in rats. Brain Res (1995) 0.87

Combination therapy of moderate hypothermia and thrombolysis in experimental thromboembolic stroke--an MRI study. Exp Neurol (2004) 0.87

Protective effects of brain hypothermia on behavior and histopathology following global cerebral ischemia in rats. Brain Res (1992) 0.87

Post-ischaemic mild hypothermia inhibits apoptosis in the penumbral region by reducing neuronal nitric oxide synthase activity and thereby preventing endothelin-1-induced hydroxyl radical formation. Eur J Neurosci (2005) 0.87

Hypothermia and ERK activation after cardiac arrest. Brain Res (2005) 0.87

Effects of delayed intraischemic and postischemic hypothermia on a focal model of transient cerebral ischemia in rats. Stroke (2000) 0.86

Mild postischemic hypothermia limits cerebral injury following transient focal ischemia in rat neocortex. Brain Res (1996) 0.86

Articles by these authors

Progressive myopathy with up-regulation of MHC-I associated with statin therapy. Neuromuscul Disord (2007) 3.29

Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches. Lancet Neurol (2007) 1.79

Mutations in the slow skeletal muscle fiber myosin heavy chain gene (MYH7) cause laing early-onset distal myopathy (MPD1). Am J Hum Genet (2004) 1.50

Magnesium treatment and spontaneous mild hypothermia after transient focal cerebral ischemia in the rat. Brain Res Bull (2008) 1.47

Wedge-shaped medullary lesions in multiple sclerosis. J Neurol Sci (2010) 1.40

Dominant mutations in KBTBD13, a member of the BTB/Kelch family, cause nemaline myopathy with cores. Am J Hum Genet (2010) 1.38

Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis. J Clin Neurosci (2008) 1.24

Two Australian families with inclusion-body myopathy, Paget's disease of bone and frontotemporal dementia: novel clinical and genetic findings. Neuromuscul Disord (2010) 1.20

Evidence that intracellular cyclophilin A and cyclophilin A/CD147 receptor-mediated ERK1/2 signalling can protect neurons against in vitro oxidative and ischemic injury. Neurobiol Dis (2006) 1.16

Motor outcome after subcortical stroke: MEPs correlate with hand strength but not dexterity. Clin Neurophysiol (2002) 1.12

Repetitive paired-pulse TMS at I-wave periodicity markedly increases corticospinal excitability: a new technique for modulating synaptic plasticity. Clin Neurophysiol (2005) 1.05

Paraspinal and scapular myopathy associated with scleroderma. J Clin Neuromuscul Dis (2010) 1.04

Peroxiredoxin 2 overexpression protects cortical neuronal cultures from ischemic and oxidative injury but not glutamate excitotoxicity, whereas Cu/Zn superoxide dismutase 1 overexpression protects only against oxidative injury. J Neurosci Res (2007) 1.00

Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease? Mov Disord (2009) 0.97

Central motor drive and perception of effort during fatigue in multiple sclerosis. J Neurol (2006) 0.96

Characterisation of neuronal cell death in acute and delayed in vitro ischemia (oxygen-glucose deprivation) models. J Neurosci Methods (2010) 0.95

Association study of Parkin gene polymorphisms with idiopathic Parkinson disease. Arch Neurol (2003) 0.95

Improvement in aerobic capacity after an exercise program in sporadic inclusion body myositis. J Clin Neuromuscul Dis (2009) 0.95

Apolipoprotein epsilon alleles in sporadic inclusion body myositis: a reappraisal. Neuromuscul Disord (2007) 0.94

Motor outcome after subcortical stroke correlates with the degree of cortical reorganization. Clin Neurophysiol (2004) 0.94

Differential changes in long-interval intracortical inhibition and silent period duration during fatiguing hand exercise. Exp Brain Res (2006) 0.93

Reversible reorganisation of the motor cortical representation of the hand in cervical dystonia. Mov Disord (2003) 0.92

Globus pallidus stimulation improves both motor and nonmotor aspects of quality of life in advanced Parkinson's disease. Mov Disord (2007) 0.92

Changes in the functional MR signal in motor and non-motor areas during intermittent fatiguing hand exercise. Exp Brain Res (2007) 0.92

Short-interval cortical inhibition and corticomotor excitability with fatiguing hand exercise: a central adaptation to fatigue? Exp Brain Res (2005) 0.91

Dual representation of the hand in the cerebellum: activation with voluntary and passive finger movement. Neuroimage (2003) 0.90

Assessment of CMV, RSV and SYN1 promoters and the woodchuck post-transcriptional regulatory element in adenovirus vectors for transgene expression in cortical neuronal cultures. Brain Res (2006) 0.89

Post-ischemic modest hypothermia (35 degrees C) combined with intravenous magnesium is more effective at reducing CA1 neuronal death than either treatment used alone following global cerebral ischemia in rats. Exp Neurol (2005) 0.89

Posterior ponticles and rotational stenosis of vertebral arteries. A pilot study using Doppler ultrasound velocimetry and magnetic resonance angiography. J Manipulative Physiol Ther (2005) 0.88

Presence of CSF oligoclonal bands (OCB) is associated with the HLA-DRB1 genotype in a West Australian multiple sclerosis cohort. J Neurol Sci (2009) 0.88

Combined magnesium and mild hypothermia (35 degrees C) treatment reduces infarct volumes after permanent middle cerebral artery occlusion in the rat at 2 and 4, but not 6 h. Brain Res (2008) 0.87

Paired-pulse rTMS at trans-synaptic intervals increases corticomotor excitability and reduces the rate of force loss during a fatiguing exercise of the hand. Exp Brain Res (2006) 0.87

NCX3 knockout mice exhibit increased hippocampal CA1 and CA2 neuronal damage compared to wild-type mice following global cerebral ischemia. Exp Neurol (2007) 0.87

The role of the Na(+)/Ca(2+) exchanger (NCX) in neurons following ischaemia. J Clin Neurosci (2007) 0.86

Functional MRI near vascular anomalies: comparison of cavernoma and arteriovenous malformation. J Clin Neurosci (2004) 0.86

Vertebral arteries and cervical rotation: modeling and magnetic resonance angiography studies. J Manipulative Physiol Ther (2002) 0.86

Erythropoietin preconditioning in neuronal cultures: signaling, protection from in vitro ischemia, and proteomic analysis. J Neurosci Res (2006) 0.85

Evaluation of preconditioning treatments to protect near-pure cortical neuronal cultures from in vitro ischemia induced acute and delayed neuronal death. Brain Res (2002) 0.85

Enhanced corticomotor excitability with dynamic fatiguing exercise of the lower limb in multiple sclerosis. J Neurol (2008) 0.85

Reduced functional activation after fatiguing exercise is not confined to primary motor areas. Exp Brain Res (2006) 0.84

Differential activation of frontal lobe areas by lexical and semantic language tasks: a functional magnetic resonance imaging study. J Clin Neurosci (2006) 0.84

The neuroprotective efficacy of cell-penetrating peptides TAT, penetratin, Arg-9, and Pep-1 in glutamic acid, kainic acid, and in vitro ischemia injury models using primary cortical neuronal cultures. Cell Mol Neurobiol (2013) 0.84

Primary sensorimotor cortex activation with task-performance after fatiguing hand exercise. Exp Brain Res (2005) 0.84

In search of clinical neuroprotection after brain ischemia: the case for mild hypothermia (35 degrees C) and magnesium. Stroke (2009) 0.84

HLA-DR allele polymorphism and multiple sclerosis in Chinese populations: a meta-analysis. Mult Scler (2010) 0.83

AP-1 inhibitory peptides are neuroprotective following acute glutamate excitotoxicity in primary cortical neuronal cultures. J Neurochem (2009) 0.83

The effect of blood pressure (37 vs 45 mmHg) and carotid occlusion duration (8 vs 10 min) on CA1-4 neuronal damage when using isoflurane in a global cerebral ischemia rat model. Brain Res Bull (2011) 0.83

Statins may not protect against vasospasm in subarachnoid haemorrhage. J Clin Neurosci (2009) 0.83

Differential involvement of excitatory and inhibitory neurons of cat motor cortex in coincident spike activity related to behavioral context. J Neurosci (2010) 0.82

Lack of neuroprotection of inhibitory peptides targeting Jun/JNK after transient focal cerebral ischemia in spontaneously hypertensive rats. J Cereb Blood Flow Metab (2011) 0.82

Neural integration of reaching and posture: interhemispheric spike correlations in cat motor cortex. Exp Brain Res (2010) 0.81

Association of cardiovascular factors and Alzheimer's disease plasma amyloid-beta protein in subjective memory complainers. J Alzheimers Dis (2009) 0.81

Temporal aspects of passive movement-related corticomotor inhibition. Hum Mov Sci (2004) 0.81

Spinal cord involvement in multiple sclerosis: a correlative MRI and high-resolution HLA-DRB1 genotyping study. J Neurol Sci (2011) 0.81

Reduced corticomotor excitability with cyclic passive movement: a study using transcranial magnetic stimulation. Hum Mov Sci (2002) 0.81

Analysis of HLA-DRB3 alleles and supertypical genotypes in the MHC Class II region in sporadic inclusion body myositis. J Neuroimmunol (2012) 0.80

The dynamics of CD147 in Alzheimer's disease development and pathology. J Alzheimers Dis (2011) 0.80

Gabapentin can improve postural stability and quality of life in primary orthostatic tremor. Mov Disord (2005) 0.80

Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study. Mult Scler (2010) 0.80

AP-1 inhibitory peptides attenuate in vitro cortical neuronal cell death induced by kainic acid. Brain Res (2010) 0.80

Corticomotor organisation and motor function in multiple sclerosis. J Neurol (2005) 0.80

Clinical profile and HLA-DRB1 genotype of late onset multiple sclerosis in Western Australia. J Clin Neurosci (2010) 0.80

Complement-mediated muscle cell lysis: a possible mechanism of myonecrosis in anti-SRP associated necrotizing myopathy (ASANM). J Neuroimmunol (2013) 0.80

Wallenberg syndrome caused by multiple sclerosis mimicking stroke. J Clin Neurosci (2009) 0.80

The influence of non-HLA gene polymorphisms and interactions on disease risk in a Western Australian multiple sclerosis cohort. J Neuroimmunol (2013) 0.79

Pharyngeal dysphagia in inflammatory muscle diseases resulting from impaired suprahyoid musculature. Dysphagia (2011) 0.79

Motor cortex reorganisation in Parkinson's disease. J Clin Neurosci (2006) 0.79

Primary writing tremor: motor cortex reorganisation and disinhibition. J Clin Neurosci (2005) 0.79

Primary cortical neuronal cultures reduce cellular energy utilization during anoxic energy deprivation. J Neurochem (2003) 0.79

Plasticity in neurological disorders and challenges for noninvasive brain stimulation (NBS). J Neuroeng Rehabil (2009) 0.79

Inclusion body myositis: new insights into pathogenesis. Curr Opin Rheumatol (2008) 0.79

Blinded placebo crossover study of gabapentin in primary orthostatic tremor. Mov Disord (2006) 0.78

Hypothalamic lesions in multiple sclerosis. J Neurol Neurosurg Psychiatry (2010) 0.78

Modifying effects of HLA-DRB1 allele interactions on age at onset of multiple sclerosis in Western Australia. Mult Scler (2009) 0.78

Rapid slowing of maximal finger movement rate: fatigue of central motor control? Exp Brain Res (2009) 0.78

Na+/Ca2+ exchanger subtype (NCX1, NCX2, NCX3) protein expression in the rat hippocampus following 3 min and 8 min durations of global cerebral ischemia. Brain Res (2007) 0.78

Intravenous administration of magnesium is only neuroprotective following transient global ischemia when present with post-ischemic mild hypothermia. Brain Res (2004) 0.78

Seasonal occurrence of relapses in inflammatory myopathies: a preliminary study. J Neurol (2002) 0.78

Investigation of age-related changes in LMNA splicing and expression of progerin in human skeletal muscles. Int J Clin Exp Pathol (2013) 0.78

Spinal muscular atrophy and the antiapoptotic role of survival of motor neuron (SMN) protein. Mol Neurobiol (2013) 0.77

Normal and aberrant splicing of LMNA. J Med Genet (2014) 0.77

Efficacy of mild hypothermia (35°C) and moderate hypothermia (33°C) with and without magnesium when administered 30min post-reperfusion after 90min of middle cerebral artery occlusion in Spontaneously Hypertensive rats. Brain Res (2013) 0.77

HLA-DRB1 allele heterogeneity influences multiple sclerosis severity as well as risk in Western Australia. J Neuroimmunol (2009) 0.77

High level over-expression of different NCX isoforms in HEK293 cell lines and primary neuronal cultures is protective following oxygen glucose deprivation. Neurosci Res (2012) 0.77

Low level of systemic autoimmunity in Western Australian multiple sclerosis patients. Mult Scler (2010) 0.76

FAST-Mag protocol with or without mild hypothermia (35°C) does not improve outcome after permanent MCAO in rats. Magnes Res (2013) 0.76

Spike-timing-related plasticity is preserved in Parkinson's disease and is enhanced by dopamine: evidence from transcranial magnetic stimulation. Neurosci Lett (2008) 0.76

Investigation of splicing changes and post-translational processing of LMNA in sporadic inclusion body myositis. Int J Clin Exp Pathol (2013) 0.76

Proteome analysis of cortical neuronal cultures following cycloheximide, heat stress and MK801 preconditioning. Proteomics (2005) 0.76

Primary over-expression of AβPP in muscle does not lead to the development of inclusion body myositis in a new lineage of the MCK-AβPP transgenic mouse. Int J Exp Pathol (2013) 0.75

Magnesium may provide further benefit to hypothermia following perinatal asphyxia encephalopathy. J Perinat Med (2015) 0.75

Preface. Handb Clin Neurol (2007) 0.75

Comparison of the efficacy of mild hypothermia (35°c) and moderate hypothermia (33°c), alone or combined with magnesium treatment, when commenced 2 or 4 hours after global cerebral ischemia in rats. Ther Hypothermia Temp Manag (2011) 0.75

Advances and challenges in developing a therapy for spinal muscular atrophy. Expert Rev Neurother (2015) 0.75

A functional MRI protocol for localizing language comprehension in the human brain. Brain Res Brain Res Protoc (2003) 0.75

Erythropoietin increases neuronal NDPKA expression, and NDPKA up-regulation as well as exogenous application protects cortical neurons from in vitro ischemia-related insults. Cell Mol Neurobiol (2014) 0.75